Klaria's business concept is to develop and commercialize innovative products
Klaria Pharma Holding has raised $2.6M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in June 2026.
Klaria Pharma Holding's investors include EISMEA.
Klaria Pharma Holding is headquartered in Uppsala, Sweden.
Klaria's business concept is to develop and commercialize innovative products
Klaria Pharma Holding is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Klaria Pharma Holding — Funding & Investors." VCBacked, June 5, 2026, https://www.vcbacked.co/company/klaria-pharma-holding. Accessed November 13, 2026.
VCBacked. (2026). Klaria Pharma Holding — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/klaria-pharma-holding
{{cite web |title=Klaria Pharma Holding — Funding & Investors |url=https://www.vcbacked.co/company/klaria-pharma-holding |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Klaria Pharma Holding? Request a listing update